BlackRock Fund Advisors’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

BlackRock Fund Advisors’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,709	Closed	-$2K	–	4345
2016 Q2	$2K	Buy	1,709 +128	+8%	+$205	﹤0.01%	4253
2016 Q1	$2K	Buy	1,581 +308	+24%	+$367	﹤0.01%	4257
2015 Q4	$2K	Buy	+1,273	New	+$2.04K	﹤0.01%	4327

Other funds holding ECTE

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BlackRock Fund Advisors's ECTE Position: Q3 2016 in Review

BlackRock Fund Advisors sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 1,709 shares — an estimated $2K sold.

BlackRock Fund Advisors first reported a position in ECTE in Q4 2015 and held it in 3 quarters. The position peaked at $2K in Q2 2016. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

BlackRock Fund Advisors reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
BlackRock Fund Advisors sold 1,709 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $2K.
BlackRock Fund Advisors first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2015 and held it in 3 quarters.
BlackRock Fund Advisors's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $2K in Q2 2016.
2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on BlackRock Fund Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.